- Home
- CRTO vs TMDX Comparison
CRTO vs TMDX Comparison
Compare CRTO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRTO
- TMDX
- Stock Information
- Founded
- CRTO 2005
- TMDX 1998
- Country
- CRTO France
- TMDX United States
- Employees
- CRTO N/A
- TMDX N/A
- Industry
- CRTO Advertising
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRTO Consumer Discretionary
- TMDX Health Care
- Exchange
- CRTO Nasdaq
- TMDX Nasdaq
- Market Cap
- CRTO 2.4B
- TMDX 2.1B
- IPO Year
- CRTO 2013
- TMDX 2019
- Fundamental
- Price
- CRTO $43.17
- TMDX $61.70
- Analyst Decision
- CRTO Buy
- TMDX Buy
- Analyst Count
- CRTO 10
- TMDX 11
- Target Price
- CRTO $51.11
- TMDX $116.10
- AVG Volume (30 Days)
- CRTO 461.8K
- TMDX 1.9M
- Earning Date
- CRTO 02-05-2025
- TMDX 10-28-2024
- Dividend Yield
- CRTO N/A
- TMDX N/A
- EPS Growth
- CRTO 1182.57
- TMDX N/A
- EPS
- CRTO 1.63
- TMDX 0.94
- Revenue
- CRTO $1,946,556,000.00
- TMDX $401,090,000.00
- Revenue This Year
- CRTO N/A
- TMDX $81.65
- Revenue Next Year
- CRTO $5.96
- TMDX $23.60
- P/E Ratio
- CRTO $26.63
- TMDX $65.84
- Revenue Growth
- CRTO N/A
- TMDX 109.09
- 52 Week Low
- CRTO $23.87
- TMDX $59.72
- 52 Week High
- CRTO $49.93
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- CRTO 67.69
- TMDX 30.60
- Support Level
- CRTO $41.29
- TMDX $63.43
- Resistance Level
- CRTO $43.59
- TMDX $66.44
- Average True Range (ATR)
- CRTO 1.15
- TMDX 4.32
- MACD
- CRTO 0.08
- TMDX 0.33
- Stochastic Oscillator
- CRTO 93.34
- TMDX 10.42
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.